"FDA has tools that could mitigate opioid risks more effectively if the agency would be more assertive in using its power to control opioid prescribing, manufacturing, and distribution."
Unfortunately for those who turn to generics to save money, the FDA relies heavily on the honor system with foreign manufacturers, and U.S. consumers get burned.
A report by the Environmental Working Group reveals that an estimated 2,000 untested chemicals, several of them known or suspected carcinogens, are legally present in conventional packaged foods sold in U.S. supermarkets. But this major public health concern is largely unrecognized by the Food and Drug Administration, which operates under a policy on food additives dating back to 1958.
The FDA plans to require pre-market safety assessments for gene-edited food animals, as they do for new animal drugs.
"FDA will be working with Johnson & Johnson to facilitate further investigation to substantiate that the product is authentic."
It has been a rough year for Tyson's chicken products.
"What this calls for is additional research to determine how widespread this contamination is and how high the levels are."
In her new explosive book “Bottle of Lies: The Inside Story of the Generic Drug Boom,” investigative journalist Katherine Eban works with two industry whistleblowers to expose how some manufacturers are cutting corners at the cost of quality and safety.
“The FDA oversight over the sales and marketing of these harmful products has languished for too long."